Загрузка...
International variability in the reimbursement of cancer drugs by publically funded drug programs
PURPOSE: Evaluate inter-country variability in the reimbursement of publically funded cancer drugs, and identify factors such as cost containment measures that may contribute to variability. METHODS: As of February 28, 2010, licensed indications for 10 cancer drugs (bevacizumab, bortezomib, cetuxima...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Multimed Inc.
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3364777/ https://ncbi.nlm.nih.gov/pubmed/22670106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.946 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|